A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles.
CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to enter the nucleus of tumor cells and exert its therapeutic impact, even in drug-resistant cancers. Their findings were published in ACS Applied Materials and Interfaces.
The study focused on doxorubicin, a commonly used chemotherapy drug. Prolonged treatment with this drug frequently results in the formation of resistant cells, which causes substantial difficulties in clinical use that the new approach successfully addresses, while maintaining the drug’s antitumor efficacy.
The technique is based on a simple but powerful concept: cyclic peptides (small amino acid rings) can stack and self-assemble into hollow cylindrical structures (nanotubes) on the surface of cancer cell membranes.
The molecular-scale drug delivery, created by a team led by Juan R. Granja, binds doxorubicin to these peptides and transports it to the cell nucleus via a mechanism that bypasses common drug resistance pathways, such as efflux pumps. This enables the drug to circumvent the cellular resistance mechanisms that typically render it ineffective.
Cancer cell membranes contain more negatively charged lipids than healthy cells. The cyclic peptides used in this study have a high affinity for these anionic surfaces, facilitating their interaction with tumor cells. Consequently, the peptide-drug conjugates enter resistant cells and go to the nucleus, where doxorubicin intercalates with DNA to produce its cytotoxic impact.
Critically, the efficacy of this delivery method depends on the structure of the cyclic peptide, particularly the inclusion of hydrophobic alkyl chains of specific lengths. Experimental research indicated that the chemical structure of the cyclic peptide is critical for the creation of stable nanotubes, which improves their capacity to penetrate malignant cells.
Drug resistance remains one of the most significant challenges in cancer therapy. Many tumors evolve systems to actively evade drugs, significantly reducing the efficacy of existing treatments. In this situation, cyclic peptides serve as multifunctional delivery vehicles, both enhancing uptake and shielding the drug from premature expulsion from tumor cells, allowing doxorubicin to enter cells that would otherwise reject it.
This technique, which combines selectivity, effective transport, and controlled drug release, opens the door to novel combination chemotherapies in which peptide-based nanotechnology might be a potent ally against cancer. Laboratory studies showed that versions of the peptide with ten carbon alkyl tails were the most effective, both in penetrating drug-resistant ovarian cancer cells and delivering doxorubicin to the nucleus.
The scientists anticipate that this method could spur the development of novel treatment techniques for difficult-to-treat tumors.
Journal Reference:
Vilela-Picos, M. et.al. (2025). Self-Assembling Cyclic Peptide Nanotubes for the Delivery of Doxorubicin into Drug-Resistant Cancer Cells. ACS Applied Materials and Interfaces. doi.org/10.1021/acsami.5c05264.
News
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
